Fierce BD&L Summit for Life Sciences: Deal-Making Insights for the Life Sciences Industry

Successfully identify and execute strategic partnerships, licensing, and M&A Deals

The past year has been a challenging time for life sciences deal-making, with biotech capital markets in a state of flux and the economic climate uncertain. Developing a comprehensive business development strategy for the coming year is not only crucial for future success, but it may also be necessary for the very survival of companies in the industry, as the uncertainty and volatility of the market may continue in the months ahead.